Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chong Lu, Yikui Zhao, Yan Cao, Li Liu, Shanshan Wu, Dongbin Li, Shuang Liu, Shuyuan Xiao, Yafen Wei & Xinyu Li. (2021) MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose. Clinical Interventions in Aging 16, pages 1185-1191.
Read now
Read now
Fabio Di Domenico, Ilaria Zuliani & Antonella Tramutola. (2019) Shining a light on defective autophagy by proteomics approaches: implications for neurodegenerative illnesses. Expert Review of Proteomics 16:11-12, pages 951-964.
Read now
Read now
Articles from other publishers (44)
Marzia Perluigi, Fabio Di Domenico & D. Allan Butterfield. (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiological Reviews 104:1, pages 103-197.
Crossref
Crossref
Yixian Li, Peng Yang, Ran Meng, Shuting Xu, Lingling Zhou, Kang Qian, Pengzhen Wang, Yunlong Cheng, Dongyu Sheng, Minjun Xu, Tianying Wang, Jing Wu, Jinxu Cao & Qizhi Zhang. (2023) Multidimensional autophagy nano-regulator boosts Alzheimer’s disease treatment by improving both extra/intraneuronal homeostasis. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Samin Davoody, Afsaneh Asgari Taei, Pariya Khodabakhsh & Leila Dargahi. (2023)
mTOR
signaling and Alzheimer's disease: What we know and where we are?
. CNS Neuroscience & Therapeutics.
Crossref
Crossref
Ya-Li Wang, Jian-Gang Wang, Shuling Guo, Fang-Li Guo, En-Jie Liu, Xin Yang, Bingyan Feng, Jian-Zhi Wang, Martin Vreugdenhil & Cheng-Biao Lu. (2023) Oligomeric β-Amyloid Suppresses Hippocampal γ-Oscillations through Activation of the mTOR/S6K1 Pathway. Aging and disease, pages 0.
Crossref
Crossref
Kaylin Hwang, Rahil N. Vaknalli, Kwaku Addo-Osafo, Mariane Vicente & Keith Vossel. (2022) Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Shaobin Yang, Yaqin Du, Xiaoqian Zhao, Chendong Wu & Peng Yu. (2022) Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease. Cells 11:11, pages 1735.
Crossref
Crossref
Shuting Xu, Peng Yang, Kang Qian, Yixian Li, Qian Guo, Pengzhen Wang, Ran Meng, Jing Wu, Jinxu Cao, Yunlong Cheng, Minjun Xu & Qizhi Zhang. (2022) Modulating autophagic flux via ROS-responsive targeted micelles to restore neuronal proteostasis in Alzheimer's disease. Bioactive Materials 11, pages 300-316.
Crossref
Crossref
Jon Ondaro, Haizea Hernandez-Eguiazu, Maddi Garciandia-Arcelus, Raúl Loera-Valencia, Laura Rodriguez-Gómez, Andrés Jiménez-Zúñiga, Julen Goikolea, Patricia Rodriguez-Rodriguez, Javier Ruiz-Martinez, Fermín Moreno, Adolfo Lopez de Munain, Ian James Holt, Francisco Javier Gil-Bea & Gorka Gereñu. (2022) Defects of Nutrient Signaling and Autophagy in Neurodegeneration. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Chuan Qin, Lin Bai, Yongning Li & Kewei Wang. (2022) The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer’s disease: crosstalk between autophagy and apoptosis. Stem Cell Research & Therapy 13:1.
Crossref
Crossref
Marzia Perluigi, Fabio Di Domenico & D. Allan Butterfield. 2022. The Neurobiology of Aging and Alzheimer Disease in Down Syndrome. The Neurobiology of Aging and Alzheimer Disease in Down Syndrome
75
96
.
Disha Agarwal, Ruchika Kumari, Ashal Ilyas, Shweta Tyagi, Rajnish Kumar & Nitesh Kumar Poddar. (2021) Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease. International Journal of Biological Macromolecules 192, pages 895-903.
Crossref
Crossref
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi & D. Allan Butterfield. (2021) The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease. Free Radical Biology and Medicine 176, pages 16-33.
Crossref
Crossref
Elham Razani, Atieh Pourbagheri-Sigaroodi, Ava Safaroghli-Azar, Anahita Zoghi, Mahsa Shanaki-Bavarsad & Davood Bashash. (2021) The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?. Cell Stress and Chaperones 26:6, pages 871-887.
Crossref
Crossref
M. Perluigi, F. Di Domenico, E. Barone & D.A. Butterfield. (2021) mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder. Free Radical Biology and Medicine 169, pages 382-396.
Crossref
Crossref
Namrata P. Nailwal & Gaurav M. Doshi. (2021) Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation. Inflammopharmacology 29:3, pages 617-640.
Crossref
Crossref
Albert Garcia-Romeu, Sean Darcy, Hillary Jackson, Toni White & Paul Rosenberg. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
287
317
.
Yun Cao, Bingjin Liu, Weiqi Xu, Lin Wang, Fangxiao Shi, Na Li, Ying Lei, Jianzhi Wang, Qing Tian & Xinwen Zhou. (2020) Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice. Brain Research Bulletin 162, pages 166-179.
Crossref
Crossref
Olga Corti, Klas Blomgren, Angelo Poletti & Philip M. Beart. (2020) Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases. Journal of Neurochemistry 154:4, pages 354-371.
Crossref
Crossref
Yi Liu, Siyi Xu, Huijie Bian, Yi Qian, Huiya Li, Shu Shu, Jiang Chen, Xiang Cao, Yue Gu, Jiali Jin, Xi Zhang, Yun Xu & Xiaolei Zhu. (2020) Xingnaojing ameliorates synaptic plasticity and memory deficits in an Aβ1–42 induced mouse model of Alzheimer's disease. Journal of Pharmacological Sciences 143:4, pages 245-254.
Crossref
Crossref
Chiara Lanzillotta, Ilaria Zuliani, Chirag Vasavda, Solomon H. Snyder, Bindu D. Paul, Marzia Perluigi, Fabio Di Domenico & Eugenio Barone. (2020) BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain—Implications for Neurodegeneration. Antioxidants 9:8, pages 671.
Crossref
Crossref
Tiffany J. Rios-Fuller, Melanie Mahe, Beth Walters, Dounia Abbadi, Sandra Pérez-Baos, Abhilash Gadi, John J. Andrews, Olga Katsara, C. Theresa Vincent & Robert J. Schneider. (2020) Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs). International Journal of Molecular Sciences 21:15, pages 5301.
Crossref
Crossref
Olja Mijanović, Ana Branković, Anton V. Borovjagin, Denis V. Butnaru, Evgeny A. Bezrukov, Roman B. Sukhanov, Anastasia Shpichka, Peter Timashev & Ilya Ulasov. (2020) Battling Neurodegenerative Diseases with Adeno-Associated Virus-Based Approaches. Viruses 12:4, pages 460.
Crossref
Crossref
Fabiana Novellino, Valeria Saccà, Annalidia Donato, Paolo Zaffino, Maria Francesca Spadea, Marco Vismara, Biagio Arcidiacono, Natalia Malara, Ivan Presta & Giuseppe Donato. (2020) Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases. International Journal of Molecular Sciences 21:3, pages 1115.
Crossref
Crossref
Ping Yin, Shuang Wang, Yafen Wei, Xu Wang, Jingdian Zhang, Xiang Yin, Jiachun Feng & Mingqin Zhu. (2020) Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-β42 in Neuron-Microglia Co-Culture Models. Journal of Alzheimer's Disease 73:2, pages 503-515.
Crossref
Crossref
Xia Jiang, Lin-Lin Chen, Zhou Lan, Fan Xiong, Xiang Xu, Yang-Yang Yin, Ping Li & Ping Wang. (2019) Icariin Ameliorates Amyloid Pathologies by Maintaining Homeostasis of Autophagic Systems in Aβ1–42-Injected Rats. Neurochemical Research 44:12, pages 2708-2722.
Crossref
Crossref
Ping Yin, Xu Wang, Shuang Wang, Yafen Wei, Jiachun Feng & Mingqin Zhu. (2019) Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease. Frontiers in Cellular Neuroscience 13.
Crossref
Crossref
Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi & D. Allan Butterfield. (2019) Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives. CNS Drugs 33:10, pages 957-969.
Crossref
Crossref
Xuehui Liu, Lei Wei, Qiongye Dong, Liyang Liu, Michael Q. Zhang, Zhen Xie & Xiaowo Wang. (2019) A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass. Aging 11:12, pages 4011-4031.
Crossref
Crossref
Fabio Di Domenico, Antonella Tramutola, Eugenio Barone, Chiara Lanzillotta, Olivia Defever, Andrea Arena, Ilaria Zuliani, Cesira Foppoli, Federica Iavarone, Federica Vincenzoni, Massimo Castagnola, D. Allan Butterfield & Marzia Perluigi. (2019) Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome. Redox Biology 23, pages 101162.
Crossref
Crossref
Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Zahra Abbasabadi, Nady Braidy & Seyed Mohammad Nabavi. (2018) Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective. Journal of Cellular Physiology 234:3, pages 2447-2459.
Crossref
Crossref
Zeba Mueed, Pallavi Tandon, Sanjeev Kumar Maurya, Ravi Deval, Mohammad A. Kamal & Nitesh Kumar Poddar. (2019) Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development. Frontiers in Neuroscience 12.
Crossref
Crossref
Baruh Polis, KolluruD Srikanth, Vyacheslav Gurevich, Hava Gil-Henn & AbrahamO Samson. (2019) L-Norvaline, a new therapeutic agent against Alzheimer’s disease. Neural Regeneration Research 14:9, pages 1562.
Crossref
Crossref
Akiko Satoh & Koichi M. Iijima. (2019) Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer’s disease pathogenesis: Potential strategies to protect the LC against aging. Brain Research 1702, pages 17-28.
Crossref
Crossref
Antonella Tramutola, Chiara Lanzillotta, Eugenio Barone, Andrea Arena, Ilaria Zuliani, Luciana Mosca, Carla Blarzino, D. Allan Butterfield, Marzia Perluigi & Fabio Di Domenico. (2018) Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome. Translational Neurodegeneration 7:1.
Crossref
Crossref
Gurjinder Kaur, Sebastien A. Gauthier, Rocio Perez-Gonzalez, Monika Pawlik, Amol Bikram Singh, Benjamin Cosby, Panaiyur S. Mohan, John F. Smiley & Efrat Levy. (2018) Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome. Neurobiology of Disease 120, pages 165-173.
Crossref
Crossref
Antonella Tramutola, Nidhi Sharma, Eugenio Barone, Chiara Lanzillotta, Andrea Castellani, Federica Iavarone, Federica Vincenzoni, Massimo Castagnola, D. Allan Butterfield, Silvana Gaetani, Tommaso Cassano, Marzia Perluigi & Fabio Di Domenico. (2018) Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:10, pages 3309-3321.
Crossref
Crossref
Zhonghua Wu, Zhengchen You, Peng Chen, Cheng Chen, Fei Chen, Jianhong Shen & Hui Xu. (2018) Matrine Exerts Antidepressant-Like Effects on Mice: Role of the Hippocampal PI3K/Akt/mTOR Signaling. International Journal of Neuropsychopharmacology 21:8, pages 764-776.
Crossref
Crossref
Antonella Caccamo, Ramona Belfiore & Salvatore Oddo. (2018) RETRACTED: Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease. Neurobiology of Aging 68, pages 1.
Crossref
Crossref
Erin E. Congdon. (2018) Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease. Frontiers in Neuroscience 12.
Crossref
Crossref
Alberto M. Martelli, Francesca Buontempo & James A. McCubrey. (2018) Drug discovery targeting the mTOR pathway. Clinical Science 132:5, pages 543-568.
Crossref
Crossref
Jaume Folch, Miren Ettcheto, Oriol Busquets, Elena Sánchez-López, Rubén Castro-Torres, Ester Verdaguer, Patricia Manzine, Saghar Poor, María García, Jordi Olloquequi, Carlos Beas-Zarate, Carme Auladell & Antoni Camins. (2018) The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia. Pharmaceuticals 11:1, pages 11.
Crossref
Crossref
Dawei Xu, Yuyu Sun, Chengniu Wang, Hao Wang, Yingjie Wang, Wei Zhao, Guofeng Bao, Fei Wang, Zhiming Cui & Bo Jiang. (2018) Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine. Neuropharmacology 128, pages 181-195.
Crossref
Crossref
Fabio Di Domenico, Antonella Tramutola, Cesira Foppoli, Elizabeth Head, Marzia Perluigi & D. Allan Butterfield. (2018) mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia. Free Radical Biology and Medicine 114, pages 94-101.
Crossref
Crossref
Haruhiro Higashida, Shin-ya Kamimura, Takeshi Inoue, Osamu Hori, Mohammad Saharul Islam, Olga Lopatina & Chiharu Tsuji. (2016) Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum. Journal of Neural Transmission 125:1, pages 17-24.
Crossref
Crossref